FLGT Q1 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$359M+4536.0% YoY

Gross Profit

$285M79.4% margin

Operating Income

$267M74.3% margin

Net Income

$201M55.8% margin

EPS (Diluted)

$6.52

QoQ Revenue Growth

+21.8%

Cash Flow

Operating Cash Flow

$233M

Free Cash Flow

$222M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$999M

Total Liabilities

$198M

Stockholders' Equity

$802M

Cash & Equivalents

$151M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$359M	$8M	+4536.0%
Gross Profit	$285M	$4M	+7620.6%
Operating Income	$267M	-$2M	+14045.8%
Net Income	$201M	-$2M	+10360.3%

Geographic Segments

UNITED STATES

$358M99%

Non Us

$2M1%